NCT07511972 2026-04-06Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNGM Biopharmaceuticals, IncPhase 2 Withdrawn
NCT07283367 2025-12-15A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.Hansoh BioMedical R&D CompanyPhase 1/2 Not yet recruiting502 enrolled